Literature DB >> 9642575

Preventing, diagnosing, and treating endophthalmitis.

S Masket.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9642575     DOI： 10.1016/s0886-3350(98)80116-8

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN： 0886-3350            Impact factor:   3.351


× No keyword cloud information.
  5 in total

1.  Penetration of topically applied levofloxacin 0.5% and ofloxacin 0.3% into the vitreous of the non-inflamed human eye.

Authors:  Tuomo Puustjärvi; Markku Teräsvirta; Pila Nurmenniemi; Jukka Lokkila; Hannu Uusitalo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

2.  [The effectiveness of the new fluoroquinolones against the normal bacterial flora of the conjunctiva].

Authors:  M J Koss; M Eder; M S Blumenkranz; V Klauss; C N Ta; H M de Kaspar
Journal:  Ophthalmologe       Date:  2007-01       Impact factor: 1.059

3.  Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives.

Authors:  M Kernt; A Kampik
Journal:  Clin Ophthalmol       Date:  2010-03-24

4.  [Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application].

Authors:  M Kernt; C Hirneiss; A S Neubauer; R G Liegl; K H Eibl; A Wolf; H de Kaspar; M W Ulbig; A Kampik
Journal:  Ophthalmologe       Date:  2010-08       Impact factor: 1.059

5.  Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics.

Authors:  Joseph S Bertino
Journal:  Clin Ophthalmol       Date:  2009-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.